An interventional study of dextrose 5% median nerve hydrodissection in Carpal Tunnel Syndrome, sponsored by Iraqi Board of medical specialties. Completed at 1 site in Iraq. Open to participants aged 20 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-29.
Sponsored by Iraqi Board of medical specialties · Not applicable, Interventional, and Treatment
to compare the efficacy of dextrose 5% with steroid hydrodissection in patients with carpal tunnel syndrome
in some cases there is prohibition to use steroid with example the patient rejection to use steroid the maneuver planned median nerve hydrodissection using ultrasound and 10 mld of dextrose 5%, unleash the median nerve for the surrounding structure and short follow up planned to be 2 weeks
589 studies on the registry are indexed under Carpal Tunnel Syndrome; 139 are open to participants now.
This study's enrollment of 40 is below the median of 60 across 445 interventional studies indexed under Carpal Tunnel Syndrome.
Browse Carpal Tunnel Syndrome studies →Iraqi Board of medical specialties is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
severe carpal tunnel syndrome failed medical management -
Exclusion Criteria:
previous failed surgery previous failed injection previous failed trial of hydrodissection cervical or brachial nerve entrapment wrist osteoarthritis or rheumatoid pregnant diabetes mellitus
-
10 mls of dextrose under ultrasound to separate the median nerve from adjacent structures
Procedure: dextrose 5% median nerve hydrodissection
10 mls of steroid used to separate the median nerve from adjacent structures
Procedure: dextrose 5% median nerve hydrodissection
planned to be a good alternative to steroid hydrodissection
pain relief in 2 weeks follow up
difference in sensory and functional symptoms post median nerve hydrodissection using dextrose and compare this effect with steroid population arm using Boston questionnaire
Time frame: 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Iraqi Board of medical specialties